Clinical heterogeneity associated with KCNA1 mutations include cataplexy and nonataxic presentations

被引:0
|
作者
Catherine A. Brownstein
Alan H. Beggs
Lance Rodan
Jiahai Shi
Meghan C. Towne
Renee Pelletier
Siqi Cao
Paul A. Rosenberg
David K. Urion
Jonathan Picker
Wen-Hann Tan
Pankaj B. Agrawal
机构
[1] Boston Children’s Hospital and Harvard Medical School,Division of Genetics and Genomics
[2] Boston Children’s Hospital and Harvard Medical School,Division of Newborn Medicine
[3] Boston Children’s Hospital and Harvard Medical School,The Manton Center for Orphan Disease Research
[4] Whitehead Institute for Biomedical Research,Department of Biomedical Sciences
[5] MIT,Department of Neurology
[6] City University of Hong Kong,undefined
[7] Boston Children’s Hospital and Harvard Medical School,undefined
来源
neurogenetics | 2016年 / 17卷
关键词
KCNA1; Cataplexy; Episodic ataxia; Whole exome sequencing; Hypertonia;
D O I
暂无
中图分类号
学科分类号
摘要
Mutations in the KCNA1 gene are known to cause episodic ataxia/myokymia syndrome type 1 (EA1). Here, we describe two families with unique presentations who were enrolled in an IRB-approved study, extensively phenotyped, and whole exome sequencing (WES) performed. Family 1 had a diagnosis of isolated cataplexy triggered by sudden physical exertion in multiple affected individuals with heterogeneous neurological findings. All enrolled affected members carried a KCNA1 c.941T>C (p.I314T) mutation. Family 2 had an 8-year-old patient with muscle spasms with rigidity for whom WES revealed a previously reported heterozygous missense mutation in KCNA1 c.677C>G (p.T226R), confirming the diagnosis of EA1 without ataxia. WES identified variants in KCNA1 that explain both phenotypes expanding the phenotypic spectrum of diseases associated with mutations of this gene. KCNA1 mutations should be considered in patients of all ages with episodic neurological phenotypes, even when ataxia is not present. This is an example of the power of genomic approaches to identify pathogenic mutations in unsuspected genes responsible for heterogeneous diseases.
引用
收藏
页码:11 / 16
页数:5
相关论文
共 50 条
  • [41] Heterogeneity of lung disease associated with NK2 homeobox 1 mutations
    Nattes, Elodie
    Lejeune, Stephanie
    Carsin, Ania
    Borie, Raphael
    Gibertini, Isabelle
    Balinotti, Juan
    Nathan, Nadia
    Marchand-Adam, Sylvain
    Thumerelle, Caroline
    Fauroux, Brigitte
    Bosdure, Emmanuelle
    Houdouin, Veronique
    Delestrain, Celine
    Louha, MaleK.
    Couderc, Remy
    De Becdelievre, Alix
    Fanen, Pascale
    Funalot, Benoit
    Crestani, Bruno
    Deschildre, Antoine
    Dubus, Jean-Christophe
    Epaud, Ralph
    RESPIRATORY MEDICINE, 2017, 129 : 16 - 23
  • [42] Heterogeneity Of Lung Disease Associated With Nk2 Homeobox 1 Mutations
    Epaud, R.
    Nattes, E.
    Lejeune, S.
    Carsin, A.
    Borie, R.
    Gibertini, I.
    Balinotti, J.
    Nathan, N.
    Marchand-Adam, S.
    Thumerelle, C.
    Fauroux, B.
    Bosdure, E.
    Houdouin, V.
    Delestrain, C.
    Louha, M.
    Couderc, R.
    De Becdelievre, A.
    Fanen, P.
    Funalot, B.
    Crestani, B.
    Dubus, J. -C.
    Deschildre, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [43] AGXT gene mutations and their influence on clinical heterogeneity of type 1 primary hyperoxaluria
    Amoroso, A
    Pirulli, D
    Florian, F
    Puzzer, D
    Boniotto, M
    Crovella, S
    Zezlina, S
    Spanò, A
    Mazzola, G
    Savoldi, S
    Ferrettini, C
    Berutti, S
    Petrarulo, M
    Marangella, M
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2001, 12 (10): : 2072 - 2079
  • [44] PDHA1 mutations and continued clinical and genetic heterogeneity: Are there gender differences?
    Emrick, Lisa
    Tang, Sha
    Emrick, Lisa
    Lee, Inn-Chi
    Wang, Guoli
    Li, Fangyuan
    Weng, Shao-Wen
    Craigen, William J.
    Wong, Lee-Jun C.
    MITOCHONDRION, 2012, 12 (05) : 561 - 561
  • [45] Novel mutations in KLF1 encoding the In(Lu) phenotype reflect a diversity of clinical presentations
    Keller, Jessica
    Vege, Sunitha
    Horn, Trina
    Keller, Margaret A.
    Leger, Regina M.
    Aeschlimann, Judith
    Lomas-Francis, Christine
    Westhoff, Connie M.
    TRANSFUSION, 2018, 58 (01) : 196 - 199
  • [46] Clinical heterogeneity of NADSYN1-associated VCRL syndrome
    Aubert-Mucca, Marion
    Janel, Caroline
    Porquet-Bordes, Valerie
    Patat, Olivier
    Touraine, Renaud
    Edouard, Thomas
    Michot, Caroline
    Tessier, Aude
    Cormier-Daire, Valerie
    Attie-Bitach, Tania
    Baujat, Genevieve
    CLINICAL GENETICS, 2023, 104 (01) : 114 - 120
  • [47] Human Clinical Phenotype Associated with FOXN1 Mutations
    Pignata, Claudio
    Fusco, Anna
    Amorosi, Stefania
    FORKHEAD TRANSCRIPTION FACTORS: VITAL ELEMENTS IN BIOLOGY AND MEDICINE, 2009, 665 : 195 - 206
  • [48] Clinical and pathological features associated with mutations in MICU1
    Childs, A. M.
    Pysden, K.
    Roper, H.
    Chow, G.
    Niks, E. H.
    Kriek, M.
    Chinnery, P. F.
    Lewis-Smith, D.
    Duchen, M.
    Szabadkai, G.
    Logan, C.
    Sheridan, E.
    Sewry, C.
    Muntoni, F.
    NEUROMUSCULAR DISORDERS, 2014, 24 (9-10) : 848 - 849
  • [49] Clinical heterogeneity of hyperinsulinism due to HNF1A and HNF4A mutations
    Tung, Joanna Yuet-ling
    Boodhansingh, Kara
    Stanley, Charles A.
    De Leon, Diva D.
    PEDIATRIC DIABETES, 2018, 19 (05) : 910 - 916
  • [50] Mutations in PDHA1; The continual clinical and genetic heterogeneity story: Are there gender differences?
    Emrick, Lisa T.
    Tang, Sha
    Lee, Inn-Chi
    Li, Fangyuan
    Weng, Shao-Wen
    Craigen, William J.
    Wong, Lee-Jun C.
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (03) : 316 - 316